Broker tips: Haleon, Informa

Deutsche Bank upgraded Haleon to 'hold' but cut its price target to 310p, citing weak growth and strategic missteps. Haleon reduced its 2026 revenue growth forecast to 2.5%. Berenberg lowered its Informa target price to 1,005p, adjusting forecasts due to event rescheduling and cautious outlook on certain regions. Informa cut its revenue guidance to 3% but maintained double-digit EPS growth expectations.

Original reporting
Published Oct 30, 2026, 4:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2026, 9:22 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Broker tips: Haleon, Informa — source image
Decision brief

The 30-second read

$HLNBearishMed
01

Why it matters

Both firms face short‑term downside pressure from analyst downgrades, but the underlying businesses remain fundamentally sound.

02

Market read

Analyst downgrades and target cuts are fresh, actionable information for traders holding or watching HLN and INF.

03

What to watch

Potential cost‑saving initiatives and upcoming product launches may mitigate the impact of lower guidance.

Relevance 6/10Novelty 6/10Timing: today

Background

The article summarizes recent analyst actions on two UK‑based health‑care and events companies, focusing on target‑price cuts and guidance revisions.

Company-level read

Ticker impact

$HLNBearishHigh confidence
Context

Deutsche Bank upgraded Haleon to hold and cut its price target to 310p after the company trimmed full‑year organic revenue growth guidance.

Expected impact

likely pressure as the market prices in weaker guidance and the target cut

Evidence & confidence

The downgrade and target reduction are fresh, material signals that directly affect valuation expectations.

Market effects

Consumer healthcare and B2B events sectors may see broader scrutiny as analysts tighten forecasts.

European listed health‑care stocks could face heightened volatility in the UK market.

Limited to investors with exposure to HLN and INF; no macro‑level spillover.

Counterpoint

Despite the downgrades, both companies retain strong cash flows and could rebound if execution improves.

Key entities

  • Deutsche Bank

    Upgraded Haleon to hold and cut its price target.

  • Berenberg

    Trimmed Informa's target price and EPS forecasts.

Related articles

$HLNHigh

Haleon margin reset and weak sales beyond oral care prompt Jefferies downgrade to 'hold'

Haleon PLC (HLN) was downgraded to 'hold' by Jefferies, which cited weak sales outside oral health and cut its price target 20% to 320p. Haleon guided to 2.5% organic sales growth, down from 4%, and Q3 growth missed consensus. Jefferies expects a 150-basis-point margin reduction by 2027 and cut its 2027 EPS forecast 11% to 19.9p. Shares trade at their lowest valuation since mid-2022.

$HLNMed

Deutsche Bank upgrades Haleon stock rating on valuation reset

Deutsche Bank upgraded Haleon (NYSE:HLN) to Hold from Sell, lowering its price target to GBP3.10. The stock has fallen 16.6% in a week, near its 52-week low. The firm cited weak growth due to industry changes and poor execution. InvestingPro notes the stock is undervalued. Haleon's Q3 2026 results missed expectations, but it maintained its full-year profit outlook.

$HLNHighAI 8/10

Haleon Sinks 14% on Growth Downgrade Despite £500 Million Buyback: “Q3 Was Below Our Expectations”

Haleon shares fell 14% after lowering its 2026 organic revenue growth outlook to around 2.5% from 3%-5%. The company announced a £500 million buyback, but it failed to offset investor concerns. CEO Brian McNamara stated Q3 results were below expectations, with organic revenue growth at 2.6%, down from 3.1% in Q2. The company's medium-term growth goal remains 4%-6%.

$GOOGLHighAI 8/10

European stocks rally after ECB and Fed holds

European stocks rose on Thursday after the ECB and Fed left interest rates unchanged. The FTSE 100 gained 0.3%, while the CAC 40 and DAX 40 climbed 1.1% and 1.3% respectively. ECB President Christine Lagarde announced her resignation. Alphabet shares fell 12% after missing earnings expectations. Shell reported better-than-expected results, while Haleon cut its revenue guidance.